4//SEC Filing
Corvus Capital Ltd. 4
Accession 0001641172-25-014963
CIK 0001896212other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 7:17 AM ET
Size
10.7 KB
Accession
0001641172-25-014963
Insider Transaction Report
Form 4
Regan Andrew
DirectorChief Executive Officer10% Owner
Transactions
- Award
Common Stock
2025-06-03$3.23/sh+154,799$500,001→ 154,799 total(indirect: See Footnote)
Holdings
- 44
Common Stock
- 20,032(indirect: See Footnote)
Common Stock
- 118(indirect: See Footnote)
Common Stock
Corvus Capital Ltd.
10% Owner
Transactions
- Award
Common Stock
2025-06-03$3.23/sh+154,799$500,001→ 154,799 total(indirect: See Footnote)
Holdings
- 20,032(indirect: See Footnote)
Common Stock
- 118(indirect: See Footnote)
Common Stock
- 44
Common Stock
Footnotes (6)
- [F1]Based on the closing price per share of the Issuer's common stock, par value $0.0001 ("Common Stock"), on June 3, 2025.
- [F2]These shares of Common Stock are owned of record by Manoira Corporation ("Manoira"). On June 3, 2025, the Issuer issued 154,799 shares of Common Stock to Manoira pursuant to that certain joint development agreement (the "Joint Development Agreement") by and between the Issuer and Manoira, representing an up-front consideration of $500,000.
- [F3]On January 24, 2025, the Issuer effected a 1-for-100 reverse stock split (the "January Reverse Split") and, on May 15, 2025, subsequently effected a 1-for-15 reverse stock split (together with the January 2025 Reverse Split, the "Reverse Splits"). The number of shares of Common Stock reported has been adjusted to give effect to the Reverse Splits.
- [F4]These shares of Common Stock are owned of record by Corvus Capital Limited ("Corvus").
- [F5]These shares of Common Stock are owned of record by Algo Holdings, Inc. ("Algo").
- [F6]Corvus is the owner of 99.0% of the equity interests of Manoira and Algo is a wholly owned subsidiary of Corvus, and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira and Algo. Dr. Andrew Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira, Algo and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership except to the extent of its or his pecuniary interest therein.
Documents
Issuer
CONDUIT PHARMACEUTICALS INC.
CIK 0001896212
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001990829
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 7:17 AM ET
- Size
- 10.7 KB